Pharmacist-provided telephonic medication therapy management in an MAPD plan

American Journal of Managed Care

Volumn 17, Issue 10, 2011, Pages

  Ward, Melea A ^a   Xu, Yihua ^a  

^a HUMANA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MEDICARE ADVANTAGE PRESCRIPTION DRUG PLAN; PHARMACIST; PRIORITY JOURNAL; PROPENSITY SCORE; TELECONSULTATION; TELEPHONIC MEDICATION THERAPY MANAGEMENT PROGRAM;

DRUG COSTS; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MEDICARE PART C; MEDICATION THERAPY MANAGEMENT; PHARMACISTS; RETROSPECTIVE STUDIES; TELEMEDICINE; UNITED STATES;

EID: 80054735830     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kohn LT, Corrigan JM, Donaldson MS, eds; Committee on Quality of Health Care in America, Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academies Press; 2000. http://www.nap.edu/ catalog.php?record-id=9728#toc. Accessed June 23, 2011.
2. Committee on Identifying and Preventing Medication Errors; Aspden P, Wolcott J, Bootman JL, Cronenwett LR, eds. Preventing Medication Errors: Quality Chasm Series. Washington, DC: National Academies Press; 2007. www.nap.edu/catalog/11623.html. Accessed June 23, 2011.
3. 108th Congress of the United States. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. http://frwebgate.access. gpo.gov/cgi-bin/getdoc.cgi?dbname=108-cong-public-laws&docid= f:publ173.108. Accessed July 12, 2009.
4. Centers for Medicare & Medicaid Services. Medicare Part D Medication Therapy Management (MTM) Program Fact Sheet. https://www. cms.gov/ PrescriptionDrugCovContra/Downloads/MTMFactSheet- 2009-06-2009-fnl.pdf. Published 2009. Accessed July 19, 2009.
5. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; Medicare prescription drug benefit: final rule. Fed Regist. 2005;70(18):4193-4585.
6. Pindolia VK, Stebelsky L, Romain RM, Luoma L, Nowak SN, Gillanders F. Mitigation of medication mishaps via medication therapy management. Ann Pharmacother. 2009;43(4):611-620.
7. Welch EK, Delate T, Chester EA, Stubbings T. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Ann Pharmacother. 2009;43(4):603-610.
8. von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45(2):197-203.
9. Sloan KL, Sales AE, Liu CF, et al. Construction and characteristics of the RxRisk-V: a VA adapted pharmacy-based case-mix instrument. Med Care. 2003;41(6):761-774.
10. Sales AE, Liu CF, Sloan KL, et al. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Med Care. 2003;41(6):753-760.
11. Farley JF, Harley CR, Devine JW. A comparison of comorbidity measurements to predict healthcare expenditures. Am J Manag Care. 2006;12(2):110-119.
12. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150(4):327-333.
13. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.
14. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: SAS Users Group International 26 Proceedings. Cary, NC: SAS Institute Inc; 2001:214-226. Paper 214-26.
15. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107.
16. Normand ST, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following an acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387-398. (Pubitemid 32303462)
17. Farley JF, Cline RR, Schommer JC, Hadsall RS, Nyman JA. Retrospective assessment of medicaid step-therapy prior authorization policy for atypical antipsychotic medications. Clin Ther. 2008;30(8):1524-1539.
18. Blough DK. Using generalized linear models to assess medical care costs. Health Serv Outcomes Res Methodol. 2000;1(2):185-202. (Pubitemid 32798848)
19. Blum J, Center for Drug and Health Plan Choice, Centers for Medicare & Medicaid Services (CMS). 2010 Call Letter 2010. Pages 68-73. https://www.cms.gov/PrescriptionDrugCovContra/ Downloads/2010CallLetter.pdf. Published March 30, 2009. Accessed September 1, 2011.
20. Centers for Medicare & Medicaid Services. 2010 Medicare Part D Medication Therapy Management (MTM) Programs. https://www.cms. gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet.pdf. Accessed January 4, 2011.
21. Barnett MJ, Frank J, Wehring H, et al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009;15(1):18-31.
22. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc. 2009;499(3):383-391.
23. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173-184.
24. Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal Beneficiaries. J Manag Care Pharm. 2009;15(1):32-41.